Zenagamtide vs Semaglutide for Weight Loss
A Research Study Investigating How Well the Medicine Zenagamtide Helps People With Excess Body Weight Lose Weight Compared to Semaglutide
- Age
- 18 and older
- Sex
- Any
- Trial phase
- Phase 3
- Study type
- Interventional
- Purpose
- Treatment
- Participants needed
- 650 (estimated)
- Sponsor
- Novo Nordisk A/S · Industry
This trial is looking for adults who are overweight or obese to test how well a new medicine, zenagamtide, helps with weight loss compared to another medicine called semaglutide. Participants will need to meet certain health requirements to join.
You may be able to join if
- I am 18 years old or older
- I am male or female (sex at birth)
You may not be able to join if
- I have a glycated hemoglobin (HbA1c) level of 6.5% or higher
- I have a history of type 1 or type 2 diabetes
- I have taken glucagon-like-peptide-1 (GLP-1) medications in the past year
Summarized in plain language from this trial's official eligibility criteria. The full criteria are further down this page — only the research team can confirm whether you qualify.
Think this trial could be right for you?
Answer three quick questions written from this study's own rules to see if you may qualify. No account needed to find out.
Check Your EligibilityThe purpose of this study is to find out if zenagamtide is safe and effective for treating participants who have excess body weight compared to treatment with semaglutide.
Loading trial locations…